Chang W - Search Results

1

Construction and validation of a T cell proliferation regulator-related signature for predicting prognosis and immunotherapy response in lung adenocarcinoma.

Chang W, Li H, Cheng Y, He H, Ou W, Wang SY. Chang W, et al. Front Immunol. 2023 Apr 4;14:1171145. doi: 10.3389/fimmu.2023.1171145. eCollection 2023. Front Immunol. 2023. PMID: 37081889 Free PMC article.

2

Identification and Validation of UPF1 as a Novel Prognostic Biomarker in Renal Clear Cell Carcinoma.

Wu C, Li H, Chang W, Zhong L, Zhang L, Wen Z, Mai S. Wu C, et al. Among authors: chang w. Genes (Basel). 2022 Nov 20;13(11):2166. doi: 10.3390/genes13112166. Genes (Basel). 2022. PMID: 36421841 Free PMC article.

3

Development of a copper metabolism-related gene signature in lung adenocarcinoma.

Chang W, Li H, Zhong L, Zhu T, Chang Z, Ou W, Wang S. Chang W, et al. Among authors: chang z. Front Immunol. 2022 Nov 29;13:1040668. doi: 10.3389/fimmu.2022.1040668. eCollection 2022. Front Immunol. 2022. PMID: 36524120 Free PMC article.

4

Identification of an Amino Acid Metabolism-Related Gene Signature for Predicting Prognosis in Lung Adenocarcinoma.

Chang W, Li H, Wu C, Zhong L, Zhu T, Chang Z, Ou W, Wang S. Chang W, et al. Among authors: chang z. Genes (Basel). 2022 Dec 6;13(12):2295. doi: 10.3390/genes13122295. Genes (Basel). 2022. PMID: 36553562 Free PMC article.

5

Adjuvant icotinib versus observation in patients with completely resected EGFR-mutated stage IB NSCLC (GASTO1003, CORIN): a randomised, open-label, phase 2 trial.

Ou W, Li N, Wang BX, Zhu TF, Shen ZL, Wang T, Chang WG, Chang ZH, Hu XX, Pu Y, Ding LM, Wang SY. Ou W, et al. Among authors: chang wg, chang zh. EClinicalMedicine. 2023 Feb 3;57:101839. doi: 10.1016/j.eclinm.2023.101839. eCollection 2023 Mar. EClinicalMedicine. 2023. PMID: 36816343 Free PMC article.

6

A novel zinc metabolism-related gene signature to predict prognosis and immunotherapy response in lung adenocarcinoma.

Chang W, Li H, Ou W, Wang SY. Chang W, et al. Front Immunol. 2023 Mar 24;14:1147528. doi: 10.3389/fimmu.2023.1147528. eCollection 2023. Front Immunol. 2023. PMID: 37033934 Free PMC article.

7

PD1^hi CD200^hi CD4⁺ exhausted T cell increase immunotherapy resistance and tumour progression by promoting epithelial-mesenchymal transition in bladder cancer.

Wu C, Duan L, Li H, Liu X, Cai T, Yang Y, Yin Y, Chang W, Zhong L, Zhang L, Cheng Y, Qin H, Wen Z, Wang H, Mai S. Wu C, et al. Among authors: chang w. Clin Transl Med. 2023 Jun;13(6):e1303. doi: 10.1002/ctm2.1303. Clin Transl Med. 2023. PMID: 37313656 Free PMC article.

8

TP53 Mutations in Esophageal Squamous Cell Carcinoma.

Zhong L, Li H, Chang W, Ao Y, Wen Z, Chen Y. Zhong L, et al. Among authors: chang w. Front Biosci (Landmark Ed). 2023 Sep 24;28(9):219. doi: 10.31083/j.fbl2809219. Front Biosci (Landmark Ed). 2023. PMID: 37796679 Free article. Review.

9

Overexpression of PSAT1 is Correlated with Poor Prognosis and Immune Infiltration in Non-Small Cell Lung Cancer.

Li H, Wu C, Chang W, Zhong L, Gao W, Zeng M, Wen Z, Mai S, Chen Y. Li H, et al. Among authors: chang w. Front Biosci (Landmark Ed). 2023 Oct 19;28(10):243. doi: 10.31083/j.fbl2810243. Front Biosci (Landmark Ed). 2023. PMID: 37919070 Free article.

10

Development and validation of a disulfidptosis and disulfide metabolism-related risk index for predicting prognosis in lung adenocarcinoma.

Zhong L, Chang W, Luo B, Gao W, He H, Fang M, Li H, Wen Z, Chen Y. Zhong L, et al. Among authors: chang w. Cancer Cell Int. 2024 Jan 2;24(1):2. doi: 10.1186/s12935-023-03204-1. Cancer Cell Int. 2024. PMID: 38167017 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

10,784 results

Search Page